$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Combined diffusion/osmotic pumping drug delivery system 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/24
  • A61K-009/44
출원번호 US-0483282 (2000-01-14)
발명자 / 주소
  • Joaquina Faour AR
출원인 / 주소
  • Osmotica Corp. VG
대리인 / 주소
    Rick Matos
인용정보 피인용 횟수 : 102  인용 특허 : 8

초록

Delivery devices capable of delivering one or more active substances by diffusion through plural micropores in the membrane or by osmotic pumping through one or more preformed passageways in the membrane are provided. The device has an about centrally located expandable core completely surrounded by

대표청구항

1. A device for the controlled delivery of active agents to an environment of use, wherein the device comprises:a) a core located approximately at the center of the device and comprising at least one expandable hydrophilic polymer and, optionally, an osmagent, said core being able to absorb fluids f

이 특허에 인용된 특허 (8)

  1. Zentner Gaylen M. (Lawrence KS) Rork Gerald S. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA), Controlled porosity osmotic pump.
  2. Staniforth John N. (Bath GB2), Controlled release device with an impermeable coating having an orifice for release of drug.
  3. Theeuwes Felix (Los Altos CA), Device for dispensing drug by combined diffusional and osmotic operations.
  4. Fekete Pal (Budapest HUX) Kiraly nee Ignacz Maria (Budapest HUX) Sipos Gabor (Budapest HUX) Jambor nee Hoffmann Zsuzsanna (Budapest HUX) Ujfalussy Gyorgy (Budapest HUX) Gora nee Hernyes Magdolna (Bud, Diffusion-osmotic controlled drug-release pharmaceutical composition and process for preparing same.
  5. Curatolo William J. (Niantic CT), Dispensing device powered by hydrogel.
  6. Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA) Theeuwes Felix (Los Altos CA) Cortese Richard (Cupertino CA), Dosage form for delivering diltiazem.
  7. Wong Patrick S. L. (Hayward CA) Barclay Brian L. (Sunnyvale CA) Deters Joseph C. (Mt. View CA) Theeuwes Felix (Los Altos CA), Osmotic device for administering certain drugs.
  8. Ayer Atul D. (Mt. View CA), Osmotic device with inert core.

이 특허를 인용한 특허 (102)

  1. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  2. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  3. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  4. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  5. Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-Wei; Scholle, Michael D.; Gordon, Nathaniel C.; Crameri, Andreas; Popkov, Mikhail, Biologically active proteins having increased in vivo and/or in vitro stability.
  6. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  7. Schellenberger, Volker; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin, Coagulation factor IX compositions and methods of making and using same.
  8. Faour, Joaquina, Combined diffusion/osmotic pumping drug delivery system.
  9. Meyer, Glenn A.; Faour, Joaquina; Pastini, Ana Cristina; Befumo, Marcelo Fernando, Composition and method for treating neurological disease.
  10. Meyer, Glenn A.; Faour, Joaquina; Pastini, Ana Cristina; Befumo, Marcelo Fernando, Composition and method for treating neurological disease.
  11. Stemmer, Willem P.; Schellenberger, Volker, Compositions comprising modified biologically active polypeptides.
  12. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Compositions for deterring abuse of opioid containing dosage forms.
  13. Podhipleux, Nilobon; Cheng, Xiu Xiu; Lodin, Unchalee; Chen, Chih-Ming; Nangia, Avinash; Tian, Dacheng, Controlled release sodium valproate formulation.
  14. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  15. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  16. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  17. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  18. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  19. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  20. Li,Shaoling; Dong,Liang Chang; Shivanand,Padmaja; Wong,Patrick S. L., Expandable osmotic composition and coating suspension.
  21. Schellenberger, Volker; Silverman, Joshua; Wang, Chia-Wei; Spink, Benjamin; Stemmer, Willem P.; Geething, Nathan; To, Wayne; Cleland, Jeffrey L., Extended recombinant polypeptides and compositions comprising same.
  22. Schellenberger, Volker; Silverman, Joshua; Wang, Chia-wei; Spink, Benjamin; Stemmer, Willem P.; Geething, Nathan; To, Wayne; Cleland, Jeffrey L., Extended recombinant polypeptides and compositions comprising same.
  23. Schellenberger, Volker; Silverman, Joshua; Wang, Chia-wel; Spink, Benjamin; Stemmer, Willem P.; Geething, Nathan C.; To, Wayne; Cleland, Jeffrey L., Extended recombinant polypeptides and compositions comprising same.
  24. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Extended release opioid abuse deterrent compositions and methods of making same.
  25. Dixit, Manesh; Cheng, Xiu-Xiu; Nangia, Avinash; Chen, Chin Ming, Extended release venlafaxine formulation.
  26. Dixit,Manesh; Cheng,Xiu Xiu; Nangia,Avinash; Chen,Chih Ming, Extended release venlafaxine formulation.
  27. Dharmadhkari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh, Gastric retention system.
  28. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  29. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  30. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof.
  31. Kumar,Vijai; Dixon,David; Tewari,Divya; Wadgaonkar,Dilip B., Methods and compositions for deterring abuse of opioid containing dosage forms.
  32. Kumar,Vijai; Dixon,David; Tewari,Divya; Wadgaonkar,Dilip B., Methods and compositions for deterring abuse of opioid containing dosage forms.
  33. Kumar,Vijai; Dixon,David; Tewari,Divya; Wadgaonkar,Dilip B., Methods and compositions for deterring abuse of opioid containing dosage forms.
  34. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  35. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  36. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  37. Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-wei; Scholle, Michael D.; Popkov, Mikhail; Gordon, Nathaniel C.; Crameri, Andreas, Methods for production of unstructured recombinant polymers and uses thereof.
  38. Guido, Debora; Huang, Haiyong Hugh, Methods of preparing tamper resistant pharmaceutical formulations.
  39. Sackler, Richard S., Methods of preparing tamper resistant solid oral dosage forms.
  40. Boyd, Maurice M.; Neuman, Ronald D.; Shelton, Andrew B.; Cauthen, Wiley M.; Zee, Ralph H., Methods to deliver and maintain volatile compounds.
  41. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  42. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  43. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  44. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  45. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  46. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  47. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  48. Martin, Francis J.; Boiarski, Anthony A., Microfabricated nanopore device for sustained release of therapeutic agent.
  49. Oberegger, Werner; Zhou, Fang; Maes, Paul; Jackson, Graham; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  50. Oberegger, Werner; Zhou, Fang; Maes, Paul; Turchetta, Stefano; Jackson, Graham; Massardo, Pietro; Saleh, Mohammad Ashty, Modified release formulations of a bupropion salt.
  51. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  52. Castan, Catherine; Guimberteau, Florence; Meyrueix, Remi; Soula, Gerard, Oral medicinal product with modified release of at least one active principle in multimicrocapsular form.
  53. Kidane, Argaw; Ray, Shimul K.; Bhatt, Padmanabh P.; Bryan, Jr., Jones W., Osmotic delivery of therapeutic compounds by solubility enhancement.
  54. Feleder, Ethel C.; Meyer, Glenn A.; Ricci, Marcelo A.; Faour, Joaquina; Pastini, Ana C.; Befumo, Marcelo F., Osmotic device containing a venlafaxine salt and a salt having an ion in common.
  55. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical composition containing gelling agent.
  56. Mattern, Claudia; Pieper, Wilfried, Pharmaceutical composition for oral application and method for preparing thereof.
  57. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  58. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  59. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  60. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  61. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  62. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  63. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  64. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  65. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  66. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  67. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  68. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  69. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  70. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  71. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  72. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  73. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  74. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  75. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  76. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  77. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  78. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  79. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  80. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  81. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  82. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  83. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  84. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  85. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  86. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  87. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  88. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  89. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  90. Fleshner-Barak, Moshe; Lerner, E. Itzhak; Rosenberger, Vered; Dahan, Mazal; Makov, Yisrael, Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition.
  91. Boyd, Maurice M.; Neuman, Ronald D.; Shelton, Andrew B.; Cauthen, Wiley M.; Zee, Ralph H., Systems and methods to deliver and maintain volatile compounds.
  92. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  93. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  94. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  95. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  96. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  97. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  98. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  99. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  100. Sackler, Richard S., Tamper resistant solid oral dosage forms.
  101. Schellenberger, Volker; Stemmer, Willem P.; Wang, Chia-wei; Scholle, Michael D.; Popkov, Mikhail; Gordon, Nathaniel C.; Crameri, Andreas, Unstructured recombinant polymers and uses thereof.
  102. Burns, Jacqueline Kay, Use of .alpha.2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로